Lanean...

Why So Few Drugs for Alzheimer's Disease? Are Methods Failing Drugs?

Recent studies of Alzheimer's disease (AD) and other neuropsychiatric drug developments raise questions whether failures of some drugs occur due to flaws in methods. In three case studies of recent AD drug development failures with phenserine, metrifonate, and tarenflurbil we identified methodo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Becker, Robert E., Greig, Nigel H.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3010269/
https://ncbi.nlm.nih.gov/pubmed/20704560
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!